Treatment Costs to Prevent or Treat Upper Gastrointestinal Adverse Events Associated with NSAIDs
作者： Elham Rahme , Alan N Barkun , Viviane Adam , Marc Bardou
DOI: 10.2165/00002018-200427130-00004
关键词:
摘要: The widespread use of nonselective NSAIDs and cyclo-oxygenase (COX)-2 inhibitors has a substantial impact on healthcare budgets worldwide. cost their gastrointestinal (GI) adverse effects is major component direct received much attention in the literature. Published studies have often differed methodologies results. It important for decision makers to understand reasons these differences order make informed decisions.
springer.com
sci-hub.se 参考文章(75)
Richard E. Johnson, Mark C. Hornbrook, Roderick S. Hooker, Gary T. Woodson, Robert Shneidman, Analysis of the costs of NSAID-associated gastropathy. Experience in a US health maintenance organisation. PharmacoEconomics. ,vol. 12, pp. 76- 88 ,(1997) , 10.2165/00019053-199712010-00008
Larson Lr, Goldstein Jl, Yamashita Bd, Prevention of nonsteroidal anti-inflammatory drug-induced gastropathy: clinical and economic implications of a single-tablet formulation of diclofenac/misoprostol. The American Journal of Managed Care. ,vol. 4, pp. 687- ,(1998)
Armuzzi A, Gasbarrini A, Santoliquido A, Pola E, Pola R, Carloni E, Gasbarrini G, Cammarota G, Ojetti, Candelli M, Pignataro G, Role of sucralfate in gastrointestinal diseases. Panminerva Medica. ,vol. 42, pp. 55- 59 ,(2000)
Judith D. Bentkover, Andrew M. Baker, Herbert Kaplan, Nabumetone in elderly patients with osteoarthritis: economic benefits versus ibuprofen alone or ibuprofen plus misoprostol. PharmacoEconomics. ,vol. 5, pp. 335- 342 ,(1994) , 10.2165/00019053-199405040-00007
Catherine Chevat, Beatriz M. Pena, Maiwenn J. Al, Frans F. Rutten, Healthcare resource utilisation and costs of treating NSAID-associated gastrointestinal toxicity. A multinational perspective. PharmacoEconomics. ,vol. 19, pp. 17- 32 ,(2001) , 10.2165/00019053-200119001-00002
Ralph Crott, Nicholaos Makris, Alan Barkun, Carlo Fallone, The cost of an upper gastroduodenal endoscopy: an activity-based approach. Canadian Journal of Gastroenterology & Hepatology. ,vol. 16, pp. 473- 482 ,(2002) , 10.1155/2002/548616
Elham Rahme, Lawrence Joseph, Sheldon X. Kong, Douglas J. Watson, Jacques LeLorier, Cost of prescribed NSAID-related gastrointestinal adverse events in elderly patients. British Journal of Clinical Pharmacology. ,vol. 52, pp. 185- 192 ,(2001) , 10.1046/J.1365-2125.2001.00348.X
Steven S. Coughlin, Jacques Benichou, Douglas L. Weed, Attributable risk estimation in case-control studies Epidemiologic Reviews. ,vol. 16, pp. 51- 64 ,(1994) , 10.1093/OXFORDJOURNALS.EPIREV.A036144
François Clinard, Marc Bardou, Catherine Sgro, Nathalie Lefevre, Francis Raphael, François Paille, Monique Dumas, Patrick Hillon, Claire Bonithon-Kopp, Non-steroidal anti-inflammatory and cytoprotective drug co-prescription in general practice. A general practitioner-based survey in France. European Journal of Clinical Pharmacology. ,vol. 57, pp. 737- 743 ,(2001) , 10.1007/S00228-001-0378-5
Olof Nryén, Hans-Olov Adami, Sven Gustavsson, Lars Lööf, Anders Nyberg, Social and economic effects of non-ulcer dyspepsia. Scandinavian Journal of Gastroenterology. ,vol. 109, pp. 41- 45 ,(1985) , 10.3109/00365528509103934